Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDR | P35968 | 6/20 | 0.66 |
| ▸ | MAPKAPK2 | P49137 | 4/20 | 0.66 |
| ▸ | CSNK2A2 | P19784 | 2/20 | 0.66 |
| ▸ | CSNK2B | P67870 | 2/20 | 0.66 |
| ▸ | CSNK2A1 | P68400 | 2/20 | 0.66 |
| ▸ | AKT1 | P31749 | 1/20 | 0.66 |
| ▸ | PLK1 | P53350 | 2/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.57 |
| ▸ | PRKD3 | O94806 | 3/20 | 0.57 |
| ▸ | MAP4K4 | O95819 | 3/20 | 0.57 |
| ▸ | CHEK2 | O96017 | 3/20 | 0.57 |
| ▸ | RET | P07949 | 3/20 | 0.57 |
| ▸ | RPS6KB1 | P23443 | 3/20 | 0.57 |
| ▸ | FLT4 | P35916 | 3/20 | 0.57 |
| ▸ | FLT3 | P36888 | 3/20 | 0.57 |
| ▸ | MAPK9 | P45984 | 3/20 | 0.57 |
| ▸ | CSNK1G2 | P78368 | 3/20 | 0.57 |
| ▸ | MELK | Q14680 | 3/20 | 0.57 |
| ▸ | MINK1 | Q8N4C8 | 3/20 | 0.57 |
| ▸ | AURKB | Q96GD4 | 3/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27218186 | 0.85 | KDR (0.67) | KDRMAPKAPK2CSNK2A2CSNK2BCSNK2A1 | |
| SCHEMBL6414576 | 0.85 | KDR (0.50) | KDRMAPKAPK2CSNK2A2CSNK2BCSNK2A1 | |
| SCHEMBL6415974 | 0.84 | ITK (0.62) | KDRMAPKAPK2CSNK2A2CSNK2BCSNK2A1 | |
| SCHEMBL6408513 | 0.81 | MAPT (0.57) | KDRMAPKAPK2CSNK2A2CSNK2BCSNK2A1 | |
| SCHEMBL6417097 | 0.80 | KDM4E (0.52) | KDRMAPKAPK2CSNK2A2CSNK2BCSNK2A1 | |
| SCHEMBL2414645 | 0.78 | KDR (0.53) | KDRMAPKAPK2CSNK2A2CSNK2BCSNK2A1 | |
| SCHEMBL2418622 | 0.78 | KDR (0.53) | KDRMAPKAPK2CSNK2A2CSNK2BCSNK2A1 | |
| SCHEMBL2417245 | 0.77 | AURKA (0.52) | KDRMAPKAPK2CSNK2A2CSNK2BCSNK2A1 | |
| SCHEMBL6414579 | 0.77 | ROCK2 (0.49) | KDRCSNK2A2CSNK2BCSNK2A1DYRK1A | |
| SCHEMBL6413091 | 0.77 | MAPT (0.48) | HSP90AB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240156825-A1 | USE OF SELECTIVE VEGFR2 AND FGFR1 INHIBITORS | FOUNTAIN THERAPEUTICS INC (US) | 2024-05-16 | — | — | US | disclosed |
| US-20050026984-A1 | Substituted thieno [2,3-c] pyrazoles and their use as medicinal products | AVENTIS PHARMA S.A. (FR) | 2005-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050026984-A1 | Substituted thieno [2,3-c] pyrazoles and their use as medicinal products | TPMT, PARK7, PRNP | KDR 3206/4885MAPKAPK2 1389/4885CSNK2A2 2270/4885 |
| US-20240156825-A1 | USE OF SELECTIVE VEGFR2 AND FGFR1 INHIBITORS | FGFR1, FRS2, FGFR2 | KDR 5/4885MAPKAPK2 302/4885CSNK2A2 1174/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.